tiprankstipranks
Trending News
More News >

Srinivas Akkaraju Insider Profile

11 Followers
Srinivas Akkaraju, Director at ZS Pharma, holds 5.63M shares in Scholar Rock Holding (Ticker: SRRK), holds 4.80M shares in Alumis Inc. (Ticker: ALMS), holds 11.44M shares in Kalaris Therapeutics (Ticker: KLRS).
tipranks
Srinivas Akkaraju

Srinivas Akkaraju
ZS Pharma (ZSPH)
Director

Ranked #81,219 out of 102,596 Corporate Insiders

Profitable Transactions

32%
8 out of 25 Profitable Transactions

Average Return

-8.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$357M
64.27%
22.62%
7.66%
4.48%
0.97% Others
A breakdown of Srinivas Akkaraju's holdings

Insider Roles

Scholar Rock Holding
(SRRK)
Director
Mineralys Therapeutics, Inc.
(MLYS)
Director
Kalaris Therapeutics
(KLRS)
Director, Ten Percent Owner
Alumis Inc.
(ALMS)
Director
+2 other positions
Roles that Srinivas Akkaraju holds in companies

Most Profitable Insider Trade

Stock:
Scholar Rock Holding
(SRRK)
Rating:Informative Buy
Date:Oct 18, 2023 - Oct 18, 2024
Return:+306.20%
The most profitable trade made by Srinivas Akkaraju

Srinivas Akkaraju's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ZSPH
ZS Pharma
Dec 21, 2015
Uninformative Sell
90.00K
$0.00
Syros Pharmaceuticals
Sep 18, 2024
Director
Uninformative Buy
5.28K
$93.33
PRNB
Principia Biopharma
Sep 20, 2018
Uninformative Buy
$38.37M
KDNY
Chinook Therapeutics
Aug 11, 2023
Uninformative Sell
$0.00
JYAC
Jiya Acquisition
Scholar Rock Holding
May 23, 2025
Director
Uninformative Buy
$229.42M
Mineralys Therapeutics, Inc.
Mar 17, 2025
Director
Informative Buy
8.10M
$80.75M
vTv Therapeutics
Dec 06, 2024
Director
Uninformative Sell
$3.47M
Alumis Inc.
May 23, 2025
Director
Uninformative Buy
$15.99M
Kalaris Therapeutics
Mar 18, 2025
Director, Ten Percent Owner
Uninformative Buy
$27.35M
ARAV
Aravive
Dec 02, 2019
Informative Buy
1000.00K
$24.32K
ICPT
Intercept Pharma
May 25, 2023
Uninformative Buy
$13.05M
SGEN
Seagen
May 19, 2020
Uninformative Buy
$9.49M
GEVA
Synageva
Jun 28, 2012
Informative Sell
13.60M
List of latest transactions for each holding click on a transaction to see Srinivas Akkaraju's performance on stock

Srinivas Akkaraju insider profile FAQ

What is the percentage of profitable transactions made by Srinivas Akkaraju?
The percentage of profitable transactions made by Srinivas Akkaraju is 32%.
    What is the average return per transaction made by Srinivas Akkaraju?
    The average return per transaction made by Srinivas Akkaraju is -8.20%.
      What stocks does Srinivas Akkaraju hold?
      Srinivas Akkaraju holds: ZSPH, SYRS, PRNB, KDNY, JYAC, SRRK, MLYS, VTVT, ALMS, KLRS, ARAV, ICPT, SGEN, GEVA stocks.
        What was Srinivas Akkaraju’s latest transaction?
        Srinivas Akkaraju latest transaction was an Uninformative Buy of ―.
          What was Srinivas Akkaraju's most profitable transaction?
          Srinivas Akkaraju’s most profitable transaction was an Informative Buy of SRRK stock on October 18, 2023. The return on the trade was 306.20%.
            What is Srinivas Akkaraju's role in ZS Pharma?
            Srinivas Akkaraju's role in ZS Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.